HME News

MAR 2017

HME News is the monthly business newspaper for home medical equipment providers. This controlled circulation publication reaches 17,100 home medical equipment services providers, including traditional HME dealers & suppliers, hospital- and pharmacy-o

Issue link:

Contents of this Issue


Page 30 of 32

Medicare Market Marker The RemitDATA Denial Tracker SOURCE: REMITDATA: 901-767-9830 The RemitDATA Denial Tracker is an index of the percentage of Medicare and commercial claims rejected on a monthly basis. The most recent month's data represents an analysis of approximately 1,343,712 Medicare claims and 4,159,791 commercial claims adjudicated between Jan. 1, 2017, and Jan. 31, 2017. The index is a categorized and weighted analysis of claims fi led by RemitDATA customers. HMENEWS.COM 4/16 5/16 7/16 10/16 1/16 1/17 12/16 8/16 6/16 9/16 11/16 2/16 3/16 Most viewed stories in January 1. Providers stay grounded in retail 2. Drive DeVilbiss bows out of Medtrade Spring 3. M&A market holds steady in 2016 4. Remedy for retail 5. Stakeholders home in on Medicaid strategy 6. Quality Medical takes total control 7. VGM Fulfi llment strikes a nerve *The Medicare Market Marker provides a monthly look at the number of Medicare benefi ciaries for whom the four MACs have allowed a claims payment. SOURCE: PDAC (number of allowed benefi ciaries) E 1 3 9 0 : O X Y G E N C O N C E N T R A T O R E 0 2 6 0 : S E M I - E L E C T R I C H O S P I T A L B E D (number of allowed benefi ciaries) E 0 6 0 1 : C P A P (number of allowed benefi ciaries) K 0 0 0 1 : S T A N D A R D W H E E L C H A I R (number of allowed benefi ciaries) (number of allowed benefi ciaries) K 0 8 2 3 : P O W E R W H E E L C H A I R * * HME NEWS POLL HMEDATABANK.COM The HME DataBank has the latest Medicare reimbursement data for the top 1,000 HME providers nationally in 103 key product cat- egories, as well as for all of the products in the NCB program. You can determine your market share, look for new product opportu- nities and check out your competition using the latest available Medicare data. Go to to learn more. data! data! **We are now tracking K0823 claims with certain modifi ers (NU, UE or RR/KH) to better refl ect the actual number of new allowed benefi ciaries under the 13-month capped rental. 11/15 8/16 7/16 9/16 10/15 12/15 1/16 5/16 6/16 2/16 3/16 4/16 "The bids are not sus- tainable as we all know and fi nally CMS may be realizing this?" — E r i k S o r e n s o n , R i d g e v i e w H o m e Medical Equipment "The delay is consistent with all Trump plans to review all new major programs. The indus- try is now offi cially on the radar (especially for CPAP) where multiple government agencies are critical of abuse." —Anonymous 122,844 Region D 108,053 Region B 80,926 Region A 28,597 Region C 19,268 Region A 7,890 Region D Region B 16,489 Region B 50,128 Region D 61,248 Region C 96,473 Region A 43,720 311 Region B Region D 304 935 Region C Region A 120 43,428 Region C 17,794 Region B 15,928 Region D 18,132 Region A Month Percent denied Source: The Braff Group, 412-833-5733. The Braff Group M&A Insider Rehab (18.2, 20.4) DME (16.5, 17.1) Respiratory (12, 10.9) 11/15 8/16 7/16 9/16 10/15 12/15 1/16 5/16 6/16 2/16 3/16 4/16 11/15 8/16 7/16 9/16 10/15 12/15 1/16 5/16 6/16 2/16 3/16 4/16 11/15 8/16 7/16 9/16 10/15 12/15 1/16 5/16 6/16 2/16 3/16 4/16 11/15 8/16 7/16 9/16 10/15 12/15 1/16 5/16 6/16 2/16 3/16 4/16 This month, we examine trends in overall private equity investment activity, particularly as it relates to lower middle market activity (deals valued between $25M—$100M) vs. upper middle market activity (deals valued between $500M—$1B). While the two segments have tracked reasonably closely between 2007 and 2015, there was a signifi cant departure in 2016. Last year, while lower middle market deal volume climbed 21.3%, the upper middle market declined by nearly the same amount—20.3% (graphed fi gures are rounded). According to PitchBook, PE sponsors are searching for "relative value in smaller portfolio companies," which is another way of saying that, driven by competition from strategics with infl ated stock prices and balance sheets fl ush with cash, the upper middle market is "over-priced." "Relative value" holds true for even smaller transactions, as we have seen PE fi rms increasingly look at deals in the plus/minus $10M range, bringing more and more healthcare service providers (that tend to be smaller in size) into "play." Do you agree with CMS's decision to temporarily de- lay Round 2019? NewsPoll based on 133 respondents. 30 222,382 Region C HME NEWS / MARCH 2017 / WWW.HMENEWS.COM Databank

Articles in this issue

Links on this page

Archives of this issue

view archives of HME News - MAR 2017